Abstract: Strontium titanate (SrTiO3) and barium zirconate (BaZrO3) are made into a solid solution at a predetermined ratio. Specifically, a dielectric ceramic composition is represented by a basic composition (SrTiO3)(1-x)(BaZrO3)x (in the formula, X satisfies 0.63?X?0.95). More preferably, X satisfies 0.67?X?0.90 in this range. Such a dielectric ceramic composition may be integrated with alumina to form a composite ceramic structure.

Abstract: Barium titanate (BaTiO3) and barium zirconate (BaZrO3) are made into a solid solution at a predetermined ratio. Specifically, a dielectric ceramic composition is represented by a basic composition (BaTiO3)(1-X)(BaZrO3)X (in the formula, X satisfies 0.70?X?0.95). More preferably, X satisfies 0.73?X?0.90 in this range. Such a dielectric ceramic composition may be integrated with alumina to form a composite ceramic structure.

Abstract: A flexible package including a package body including a first side-surface film and a second side-surface film sealed in a peripheral portion such that a storage portion is formed in the package body. The package body has sealed portions formed in side edge portions such that a non-sealed portion is formed in at least one of the sealed portions. The non-sealed portion has a gas injection portion containing a gas which has a specific heat at constant volume of 0.67 kJ/kg·deg or higher at 0° C. and 1 atm. The gas injection portion has a diameter in a range of from 3 mm to 50 mm and is formed such that a repelling force is in a range of from 4 N to 30 N at 23° C. and 1 atm when an entire gas injection portion is nipped from both sides of the first and second side-surface films and squeezed until a nipped gas injection portion has a width equal to a half of the diameter of the gas injection portion.

Abstract: A compound represented by the formula (1): wherein Xa and Ya are each a single bond and the like, cancer antigen peptide A is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, R1 is a hydrogen atom, a group represented by the formula (2): wherein Xb and Yb are each a single bond and the like, cancer antigen peptide B has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, or cancer antigen peptide C, and cancer antigen peptide C has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide or an MHC class II-restricted WT1 peptide, consisting of 7-30 amino acid residues containing one cysteine residue, or a salt thereof, and the like.

Abstract: A method for inspecting a liquid droplet ejection apparatus that ejects a liquid droplet from an ejection port includes (a) ejecting the liquid droplet toward an ejection target at an inspection drive frequency that is higher than an operation drive frequency set during a normal operation; (b) measuring a characteristic of the liquid droplet deposited on a surface of the ejection target; and (c) determining that the ejection port the characteristic of which is outside a predetermined range is defective.

Abstract: A compound represented by the formula (1): wherein Xa and Ya are each a single bond and the like, cancer antigen peptide A is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, R1 is a hydrogen atom, a group represented by the formula (2): wherein Xb and Yb are each a single bond and the like, cancer antigen peptide B has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, or cancer antigen peptide C, and cancer antigen peptide C has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide or an MHC class II-restricted WT1 peptide, consisting of 7-30 amino acid residues containing one cysteine residue, or a salt thereof, and the like.

Abstract: An organic EL display panel including organic light-emission layers formed according to an inkjet method and suppressing decrease in image display quality caused by stripe unevennesses, and a method of manufacturing the same. In a bank layer forming process, openings belonging to a first array and openings belonging to a second array that is adjacent to the first in a row direction are offset with respect to one another in the column direction. In an organic light-emission layer forming process, a head unit is caused to move in a row direction, and nozzles used are switched between the first and second arrays. When a nozzle ejecting an erroneous ink volume is switched between being used and not being used, continuous forming of organic light-emission layers having a same, erroneous film thickness in the row direction is prevented. Thus, unevenness in luminance is suppressed.

Abstract: A first bonding material composition according to the present invention is a bonding material composition used when aluminum nitride sintered bodies containing a rare-earth metal oxide are bonded to each other, in which the bonding immaterial composition contains, in addition, to an O element-containing aluminum nitride raw material, (a) as a fluorine compound, at least one of a fluorine compound of an alkaline-earth metal and a fluorine compound of a rare-earth metal, or (b) as a fluorine compound, at least one of a fluorine compound of an alkaline-earth metal and a fluorine compound of a rare-earth metal, and a rare-earth metal oxide.

Abstract: A compound represented by the formula (1): wherein Xa and Ya are each a single bond and the like, cancer antigen peptide A is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, R1 is a hydrogen atom, a group represented by the formula (2): wherein Xb and Yb are each a single bond and the like, cancer antigen peptide B has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide consisting of 7-30 amino acid residues, or cancer antigen peptide C, and cancer antigen peptide C has a sequence different from that of the cancer antigen peptide A, and is an MHC class I-restricted WT1 peptide or an MHC class II-restricted WT1 peptide, consisting of 7-30 amino acid residues containing one cysteine residue, or a salt thereof, and the like.

Abstract: An ink jet device includes: an ink jet head including a nozzle through which ink droplet is ejected by applying voltage to piezoelectric element; and an ejection control unit controlling ink droplet ejection amount by varying voltage, voltage waveform of the voltage includes: preliminary vibration wave form part for preliminary drive operation of pushing ink toward outer edge of the nozzle to the extent that the droplet is not ejected; and main vibration waveform part for main drive operation of ejecting the droplet through the nozzle after the preliminary drive operation, the ejection control unit performs the preliminary and main drive operations according to the preliminary vibration waveform part and the main vibration waveform part, respectively, and proportion of displacement amount X of the voltage for the preliminary drive operation to displacement amount Y of the voltage for the main drive operation is set to 20%?X/Y?40%.

Abstract: A spoke attachment structure is provided with a main body and a cover member. The main body includes a tool engagement structure and an external thread. The cover member is disposed on an outer surface of the main body adjacent the external thread.

Abstract: A film-forming ink includes: film-forming materials containing a ?-conjugated compounds; and a liquid medium which is capable of dissolving or dispersing the film-forming material and containing a compound represented by the following formula (I), wherein the compound is one in which the substituent of at least one of R1 to R6 is a linear or branched alkyl group, and the molecular structure of the one substituent is larger than the molecular structure of another substituent, and thus, the molecular weight of the whole molecule is biased towards the side where the one substituent is present.

Abstract: An organic EL display panel including organic light-emission layers formed according to an inkjet method and suppressing decrease in image display quality caused by stripe unevennesses, and a method of manufacturing the same. In a bank layer forming process, openings belonging to a first array and openings belonging to a second array that is adjacent to the first in a row direction are offset with respect to one another in the column direction. In an organic light-emission layer forming process, a head unit is caused to move in a row direction, and nozzles used are switched between the first and second arrays. When a nozzle ejecting an erroneous ink volume is switched between being used and not being used, continuous forming of organic light-emission layers having a same, erroneous film thickness in the row direction is prevented. Thus, unevenness in luminance is suppressed.

Abstract: A liquid injector (400) injects a medical liquid into a patient whose fluoroscopic image data is to be picked up and generates injection history data corresponding to the injection, and a control box (500) registers the injection history data in a RIS (100) in association with imaging order data. Accordingly, the RIS (100) also stores the injection history data associated with the imaging order data, and therefore the injection history data can also be confirmed based on the imaging order data.

Abstract: A funnel component, and a packaging container using the funnel component are provided. A funnel component includes: a funnel portion having a diameter that is increased from a narrow opening side toward a wide opening side; a discharge portion that connects with an end portion on the narrow opening side; and a side wall portion that surrounds an opening portion, on the wide opening side, of the funnel portion, connects with the funnel portion, and is fitted into the container body. The funnel component is integrally formed by a sheet member including paper and sealant layer. A folded portion is formed, by the sheet member being folded back and welded over entire circumference, at an opening portion of the discharge portion. The packaging container is formed by the funnel component being fitted into a container body having an open end, a bottom portion, and a side wall.

Abstract: A container is provided that is used as a container permitting easy transfer into another container without spilling of contents at the time of work of refilling. The present invention relates to a container that is fitted in a container body of tubular shape having an open end, a bottom part and a side wall and that transfers contents into a preservation container. This container has: a funnel component (201) provided with a funnel (220) whose diameter decreases from a larger opening side toward a smaller opening side and provided with a plurality of ribs (228) that extend radially from the center of an opening part (222) on the smaller opening side of the funnel (220) so as to bridge a part with another part of the inner surface of the opening part (222) on the smaller opening side; and a container body.

Abstract: A packaging bag having a steam venting function capable of releasing pressure inside a package even when heating cooking is performed by a microwave oven and preventing the inside of the bag from being contaminated and the package using the packaging bag. The packaging bag includes two pieces of front and back main body films having sealant layers which are opposed to each other with the sealant layers facing inward, side seal parts, and a bottom seal part. The front body film is folded in the vicinity of the bottom seal part throughout the entire width of the bag and parallel with the bottom seal part to form a fold-in part. A steam venting port is formed in the fold-in part, and an easily peelable tape covering the steam venting port is disposed on the inside of the fold-in part throughout the width of the bag and parallel with the fold-in part, and then heat-sealed.

Abstract: The present invention was made in view of an object to produce a novel proteoglycan-containing material, and find a novel use and/or a superior effect of the proteoglycan-containing material. The present invention provides a proteoglycan-containing material obtained from fish cartilage, wherein the proteoglycan-containing material comprises an acidic saccharide component having a molecular weight of not less than 2000 kDa. The proteoglycan-containing material provides advantageous effects for skin-moisturizing and skin anti-aging, including a superior skin fibroblast proliferation effect, an effect of enhancing and improving the skin barrier function, an effect of enhancing and improving the skin's capability to produce collagen, a dermis-thickening inhibition effect, and the like.

Abstract: A liquid injector (400) injects a medical liquid into a patient whose fluoroscopic image data is to be picked up, and generates injection history data corresponding to the injection. A control box (500) allocates identification data associated with the fluoroscopic image data to the injection history data, and PACS (300) stores the fluoroscopic image data and the injection history data allocated with the identification data. The injection history data is also stored in association with the fluoroscopic image data to be stored, and hence the injection history data can also be confirmed when viewing the fluoroscopic image data.

Abstract: A bicycle wheel spoke assembly includes a spoke and a spoke nut. The spoke has a rim attachment end and a hub attachment end. The spoke nut has a main body with a cylindrical shaped outer surface and a bore extending at least partially through the main body. The outer surface has at least one axially extending rib configured for engagement with a spoke aperture of a bicycle wheel hub. The bore of the main body of the spoke nut includes threads with the hub attachment end of the spoke being threadedly secured within the bore.